ipl-logo

Rachel King's Impact On The Biotech Industry

743 Words3 Pages

Rachel King, CEO of GlycoMimetics, had a deep passion on biotechnology that made a huge impact on the biotech industry. King has hold many positions throughout her career, which made her influential in the industry. Her love for biotech lead her to become one of the nation’s leading figure in biotechnology. Due to this, King uses her passion for biotech to develop a lead drug for vaso occlusive crisis of sickle cell disease with the help of her company.
Before founding GlycoMimetics, King first studied at Dartmouth College, where she received her B.A. degree, and after that, she went to Harvard Business School in order to receive her M.B.A. degree. After receiving both degrees, she worked at Bain and Company in Boston, and at ALZA Corporation …show more content…

Around three years later, she joined Novartis
Corporation as its senior vice president for two years, and as an entrepreneur in residence at New
Enterprise Association for another two years. She then joined the boards of BIO and MdBIO and was appointed to the state Life Sciences Advisory Board. Finally, in 2003, King cofounded
GlycoMimetics, a Gaithersburg MDbased company that is working on a lead drug that can cure sickle cell diseases.
Martinez 2
GlycoMimetics serves as a biotech company based in Gaithersburg, Maryland, where the company engages in designing and developing small molecule therapeutics to mimic the functions of bioactive carbohydrates. One of the company’s lead products is the GMI1070
Rivipansel Sodium, which is a potential treatment for vaso occlusive crisis, a condition that occurs with Sickle Cell crisis. Other products include the GMI1051, a small molecular weight compound for the treatment or prevention of infections caused by pseudomonas aeruginosa.
While serving as CEO of GlycoMimetics, King served as a national voice on policy issues affecting the biotech industry, and has been involved with BIO (Biotechnology …show more content…

She even testified before the Senate Committee on Small Business and
Entrepreneurship where she reinforced the need for patent protection incentives to encourage small business innovation. Her knowledge in biotech and leadership in BIO had made an outstanding influence to everyone who was involved in BIO with her.
Rachel King’s dedication and support in the biotech industry is what made her influential in the industry. In an article in BIOWorld, King states that biotech “is not “just another business, ” but a way to make a meaningful difference in people’s lives.” What she meant is that biotech has a more significant role to play in people’s lives than just being another occupation of someone.
GlycoMimetics teamed up with Pfizer by finding data for the GMI1070, and moved on to
Phase 2 in curing sickle cell disease. In a press release, Rachel King said that they “continue to make significant progress with our pipeline programs.” In addition to this, she said that the data,
“provide additional support for testing the drug candidate in sickle cell crisis.” What King said in
Martinez 3 the press release is that Pfizer is helping out GlycoMimetics by finding data of the

Show More
Related

Henrietta Lacks: The Cause Of Cancer Cells

741 Words | 3 Pages

This was good for the world, thanks to Lacks cells, specialists can use these cells to help find cures for deadly diseases like

Read More

Henrietta Lacks's Role In Curring Disease

263 Words | 2 Pages

Henrietta Lacks, an African American tobacco farmer from southern Virginia, was diagnosed with cervical cancer at 30 years old. During her treatment at John Hopkins Hospital, one of the doctors took a piece of her tumor without her knowledge or consent and sent it to scientists who had been unsuccessfully attempting to grow tissues in culture for decades. There is no explanation as to why, but her cells never died. To this day they are still alive and have been used throughout the years to great advantages in curing diseases. Henrietta’s cells have played a part in some of the world’s most important medical advances such as the development of the polio vaccine, cloning, vitro fertilization, gene mapping, and they even went up in the first space

Read More

Henrietta Lacks Cells Alive For Medical Industry Benefits

1326 Words | 6 Pages

Lacks’ Cells Alive for Medical Industry Benefits The story of Henrietta Lacks in this reading is fascinating. By using Ms. Lacks’ cells, medical science has developed many cures. By one woman contributing her cells decades ago without her knowledge, on an involuntary basis, the impact has become mind-boggling. At the same time, it is disheartening and shaming to know that Henrietta’s family was unable to pay for medical attention for her.

Read More

The Immortal Case Of Henrietta Lacks

1245 Words | 5 Pages

Many accomplishments have been made in healthcare efforts in the last few decades; but unknowingly these accomplishments came from the sacrifice of other individuals. In the case of Henrietta Lacks, she was not even aware what she had given up. As Lacks was dying from aggressive ovarian cancer, samples of her tumor cells were taken without her knowledge or consent. The researcher, who obtained them, George Gey, uncaringly acquired them for the benefit of his lab work. This act eventually turned his profession around making him a well-known wealthy scientist.

Read More

What Are The Ethical Issues In The Immortal Life Of Henrietta Lacks

890 Words | 4 Pages

The novel The Immortal Life of Henrietta Lacks is based on a poor black woman named Henrietta Lacks who had cervical cancer in 1951. Although such a wide range of cancers all across the United States were present during her time, she, in fact, her cells, were selected and collected without consent or knowledge to develop a so called “immortal cell.” This “immortal cell” has been sold in the billions, in which the Lacks family has received absolutely nothing in return for. They were unknown and unheard of. However, the research and understanding of her cells in order to develop vaccines, immunity, cloning, etc. is the base of some parts of modern biology and medical research today.

Read More

Informative Speech On St. Jude Research Hospital

906 Words | 4 Pages

In the early 2000’s St. Jude began to expand more in staff cures and new patients. The C.E.Os. of St. Jude are Dr. Donald Pinkel (1961-1973) he was the first director and ceo of St. Jude he focused most of his time of the frequent cancer in children, he and his colleges used most of their time trying to find cures for cancer. Dr. James R. Downing is the 6th and current ceo and director of St. Jude. He works a s a Genome sequencing pioneer, and over sees the Pediatric Cancer Genome Project.

Read More

The Immortal Life Of Henrietta Lacks By Rebecca Skloot

1118 Words | 5 Pages

The deliberation of bioethics in human cell and stem cell research has flip-flopped altercations between whether stem cell research corrupts the future or if basic ethical uses in clinical research are being held to its standards. The idea of having genetically altered drugs and cells sits with people the wrong way, and with that they have come to the decision that cell research will cause more problems than it stopping them. However, while a majority of people and scientists believe genetic engineering is an evil corruption of nature’s course, genetic engineering has the greatest potential to do something great for our future, but it is our moralistic responsibility to follow the rules of bioethics. The author of The Immortal Life of Henrietta

Read More

President And CEO Of Ventria Bioscience

760 Words | 4 Pages

2.) What groups have a stake in Ventria’s actions? Identify the relevant stakeholders and for each, state its interests and sources of power. Scott Deeter, the President and CEO of Ventria Bioscience was a stakeholder, along with Dr. Raymond Rodriguez, the founder of Ventria Bioscience, and a molecular biologist on the faculty of the University of California-Davis. In his search for funding, Rodriguez approached Dr.

Read More

1918-1939 Was A Period Of Progress In Canada

996 Words | 4 Pages

(The Oxford Scientist, 2020). This shows that conditions for overall public health improved - because of both the discovery of Insulin and Penicillin. The fact that

Read More

About The Drug Companies: How They Deceive Us And What To Do About It Summary

1134 Words | 5 Pages

This book gives example after example of how the drug industry, known as “Big Pharma, discovers few genuinely innovative drugs, spends more money on

Read More

Gertrude Elion Essay

886 Words | 4 Pages

Gertrude Elion Gertrude Elion was a biochemist and pharmacologist born on January 23, 1918 in New York City.1 She extensively researched drugs “that led to the treatment of incurable illnesses such as cancer, malaria, herpes, and AIDS”, and she won and shared a Nobel Prize in Physiology or Medicine for it in 1988.1 While her research was ground-breaking, she had some significant institutional and cultural forces that shaped her career. One of these forces was her finances and education. Although Elion was an outstanding student who skipped two grades, her father was unable to pay for her college education because he had gone into bankruptcy after the stock market crash in 1929.2 Luckily, she was able to overcome this predicament because Hunter

Read More

Terminally Ill Patients Should Have Access To Experimental Drugs

653 Words | 3 Pages

The participants could also benefit future people with the same illnesses. The Abigail Alliance, created in 2001, has pushed for earlier access to over 30 experimental drugs which have since all passed the FDA’s clinical trials. The alliance was formed after Abigail Burrough had requested access into a trial on an experimental cancer drug and had only been accepted after she had become too ill to travel, she then died a month later. The extended wait times on the acceptance into trials and availability of new drugs could be major problems. According to Dr. Arthur Caplan from the University of Pennsylvania, “small biotech companies have extremely limited amounts of an experimental drug.

Read More

Shelley's Argument Against Scientific Technology

562 Words | 3 Pages

It supposes important progress in the fight against diseases such as diabetes, some cancers and others hereditary diseases. Although they have many advantages, they also pose ethical problems, often motivated by the interests and bad practices of multinational

Read More

Gene Therapy Informative Speech

1418 Words | 6 Pages

For that reason, I believe it is important to learn about this upcoming breakthrough in the science and medical field. C. Speaker Credibility: As a Biology major I have learned about DNA and cells and taken my research to the next step by studying how genes work. I also conducted an interview with my biology lab teaching assistant to learn more about the process. D. Thesis: Learning about the promise of gene therapy is important because it could change the future of medicine forever, impacting our lives, our kids’ lives and so on. E. Preview of Main Points:

Read More

Theranos Case Study

792 Words | 4 Pages

Once appraised by Silicon Valley Press tech, Theranos, a biotechnology company, is losing its name value as days go by. Elizabeth Holmes, founder and Chief Executive Officer of Theranos, was known for her unique story of how Theranos has started. Upon start of the company, Holmes claimed that the Theranos’ technology is new, but different from what is out in the market. New and innovative, this company’s propaganda attracted many people’s attentions. From the start, Holmes’ plan was to provide higher accuracy tests, multiple tests from a drop of blood, and, in bigger picture, more access to its technology to the public.

Read More

More about Rachel King's Impact On The Biotech Industry

Related Topics

Open Document